Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.

作者: R Puca , L Nardinocchi , D Givol , G D'Orazi

DOI: 10.1038/ONC.2010.183

关键词: Tumor progressionDNA damageDNA repairCancerTranscription factorTumor suppressor geneRegulatorCarcinogenesisCancer researchBiology

摘要: The p53 protein is the most studied tumor suppressor and pathway has been shown to mediate cellular stress responses that are disrupted when cancer develops. After DNA damage, activated as transcription factor directly induce expression of target genes involved in cell-cycle arrest, repair, senescence and, importantly, apoptosis. Post-translational modifications essential for activation selection genes. homeodomain-interacting kinase-2 (HIPK2) a crucial regulator apoptotic function by phosphorylating its N-terminal serine 46 (Ser46) facilitating Lys382 acetylation at C-terminus. HIPK2 numerous genotoxic agents can be deregulated tumors several conditions including hypoxia. Recent findings suggest active/inactive affect multiple unexpected ways. This makes well interesting targets therapy. Hence, understanding role activator may provide important insights process progression, also serve point diagnostic therapeutical aspects cancer.

参考文章(101)
Pierre Hainaut, Jo Milner, A structural role for metal ions in the "wild-type" conformation of the tumor suppressor protein p53. Cancer Research. ,vol. 53, pp. 1739- 1742 ,(1993)
Marco A Calzado, Florian Renner, Ana Roscic, M Lienhard Schmitz, None, HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle. ,vol. 6, pp. 139- 143 ,(2007) , 10.4161/CC.6.2.3788
Jutta Moehlenbrink, Nadja Bitomsky, Thomas G. Hofmann, Hypoxia suppresses chemotherapeutic drug-induced p53 Serine 46 phosphorylation by triggering HIPK2 degradation Cancer Letters. ,vol. 292, pp. 119- 124 ,(2010) , 10.1016/J.CANLET.2009.11.016
Valeria Di Stefano, Giovanni Blandino, Ada Sacchi, Silvia Soddu, Gabriella D'Orazi, HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function. Oncogene. ,vol. 23, pp. 5185- 5192 ,(2004) , 10.1038/SJ.ONC.1207656
Hee-Jun Wee, Dominic Chih-Cheng Voon, Suk-Chul Bae, Yoshiaki Ito, PEBP2-β/CBF-β–dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis Blood. ,vol. 112, pp. 3777- 3787 ,(2008) , 10.1182/BLOOD-2008-01-134122
K. Sakaguchi, J. E. Herrera, S.'i. Saito, T. Miki, M. Bustin, A. Vassilev, C. W. Anderson, E. Appella, DNA damage activates p53 through a phosphorylation–acetylation cascade Genes & Development. ,vol. 12, pp. 2831- 2841 ,(1998) , 10.1101/GAD.12.18.2831
Cinzia Rinaldo, Andrea Prodosmo, Francesca Siepi, Silvia Soddu, HIPK2: a multitalented partner for transcription factors in DNA damage response and development. Biochemistry and Cell Biology. ,vol. 85, pp. 411- 418 ,(2007) , 10.1139/O07-071
Ann M. Bode, Zigang Dong, Post-translational modification of p53 in tumorigenesis Nature Reviews Cancer. ,vol. 4, pp. 793- 805 ,(2004) , 10.1038/NRC1455